Skip navigation

GlobeinvestorGOLD Canada's most comprehensive investment tool.

Fund Price: $4.36 (as at November 20, 2009)  1-day chg: $-.0065 -0.15%  YTD: 36.44%

Returns as at October 31, 2009

  Fund Group Avg Index*
1 Month -2.04% -1.73% -1.38%
3 Months 5.80% 4.40% 5.32%
6 Months 25.22% 8.86% 8.32%
1 Year 18.98% 0.75% -2.75%
2 Year Avg -28.69% -14.44% -10.79%
3 Year Avg - -10.23% -8.29%
5 Year Avg - -3.76% -2.15%
10 Year Avg - -4.61% -3.99%
15 Year Avg - 3.00% 5.71%
20 Year Avg - 4.92% 7.56%
Since Inception -21.58% - -
 
2008 -54.18% -30.43% -21.92%
2007 -14.33% -6.90% -10.55%
2006 - 10.29% 15.74%
 
3 year risk - 17.85 14.81
3 year beta - 1.01 1.00

*S&P 500 Composite Total Return Idx($Cdn)

Growth of $10,000

This graph shows how a $10,000 investment in this fund would have changed in value compared with the S&P 500 Composite Total Return Idx($Cdn).

Risk Measures as at October 31, 2009

Best/Worst 12 months (since inception)
Best (ending Oct 09): 18.98 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
Worst (ending Feb 09): -60.70 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
Volatility meter (Based on 3 year standard deviation from Globefund.com)
Low VOLATILITY METER: 33 High

Fund Objectives

The principal investment objective of the QSA™ US Large Cap Value 50 Equity Fund is to provide investors with strong capital growth over the long term by investing in equity securities - principally common shares of a group of US companies selected from the S&P 500 Index. To achieve the Fund's objective, the Manager will select approximately 50 securites from the S&P 500 Index that the Manager believesare undervalued. In selecting securities for inclusion in the portfolio, the Manager uses a disciplined approach to analyze and evaluate companies. This approach is based on a proprietary security analysis model called Quantitative Security Analysis or QSA™, which evaluates the financial structure of a company by means of a mathematical analysis of its balance sheet and consensus earnings estimates in the context of the prevailing interest rate environment. The Fund may invest in or use derivative instruments for any purpose consistent with its investment objective.

Fund Facts

Fund Sponsor: Acker Finley Asset Management Inc.
Managed by: Acker Finley Asset Management Inc.
Fund Type: MF Trust
Inception Date: December 2006
Asset Class: U.S. Equity
Quartile Rank: - (3YR ending October 31, 2009)
Total Assets: $4.9 million
Mgmt Exp. Ratio (MER): 1.01%
Management Fee: 0.75%
Load Type: No Load
Globe 5-Star Rating:
RRSP Eligible:
Canadian
Min. Invest (initial):
$150,000
Subsequent:
$500
Min. Invest (initial RRSP):
$150,000
Subsequent RRSP:
$500
Closed:
No
Restricted:
Yes
Restriction:
Not Available in PQ (Min Initial Investment $150,000); min $150K or accredited investors
 
 

Asset Allocation September 30, 2009

Equity Sector Weightings September 30, 2009

Fund Geography September 30, 2009

Top Holdings as at September 30, 2009

Symbol Company Name Sector Geographic
Area		 Asset
Type		 % of
Total Assets		   Performance as at November 20, 2009
1 Year Performance (%)
EBAY-Q eBay Department Stores United States Stock 6.19   104.03 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
MRO-N Marathon Oil Integrated Oils United States Stock 6.06   68.64 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
BMY-N Bristol Myers Squibb Biotechnology & Pharmaceuticals United States Stock 5.99   26.87 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
PFE-N Pfizer Biotechnology & Pharmaceuticals United States Stock 5.87   27.06 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
LOW-N Lowes Companies Misc. Industrial Products United States Stock 5.83   26.93 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
LLY-N Eli Lilly & Co. Biotechnology & Pharmaceuticals United States Stock 5.75   22.33 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
GLW-N Corning Inc. Misc. Industrial Products United States Stock 5.64   109.85 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
WAG-N Walgreen Co. Specialty Stores United States Stock 5.32   70.55 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
MRK-N Merck & Company Biotechnology & Pharmaceuticals United States Stock 4.63   54.75 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
MDT-N Medtronic Inc. Biotechnology & Pharmaceuticals United States Stock 4.54   36.43 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)

Distribution Report (18 months up to November 20, 2009)

Frequency of Income Distributions: Variable

Frequency of Capital Gain Distributions: Quarterly

Date Income Dividend Capital Gain Total (Current Period) Trailing 12-Months Total Reinvestment Price
Mar 23, 2009 0.0060 0.0060 0.0821 2.952
Dec 16, 2008 0.0671 0.0671 0.0845 3.259
Sep 22, 2008 0.0059 0.0059 0.5501 5.424
Jun 23, 2008 0.0032 0.0032 0.5442 6.313

Portfolio Manager(s)

Acker Finley - Mgmt. Team

Acker Finley Asset Management Inc.

Start Date: December, 2006

Fund Return: -4.85%

Acker Finley focuses on achieving excellent returns for clients in all market conditions by consistently applying proprietary quantitative analysis to the investment process.

Also manages:Acker Finley Canada Focus, Acker Finley Select Canada Focus-A

View fund manager performance report





Back to top